Table 2 Successfully established primary glioma PDXs from November 2016 to May 2018
WHO grades | WHO classification | Cases of established PDXs | PDXs success rate | Latency time (weeks, median range) |
|---|---|---|---|---|
II | Diffuse astrocytoma, IDHWT | 1 | 1/3 | 11 |
III | Anaplastic OGDs, IDHMUT-1p/19qcodeleted | 1 | 60.00% (3/5) | 18 (14–22) |
Anaplastic OGDs, NOS | 2 | |||
IV | GBM, IDHWT | 7 | 87.50% (7/8) | 9 (5–22) |
Total |  | 11 | 68.75% (11/16) | 13 (5–22) |